Lakatos Peter Laszlo, Hitre Erika, Szalay Ferenc, Zinober Kerstin, Fuszek Peter, Lakatos Laszlo, Fischer Simon, Osztovits Janos, Gemela Orsolya, Veres Gabor, Papp Janos, Ferenci Peter
1st Department of Medicine, Semmelweis University, Budapest, Hungary.
BMC Cancer. 2007 Mar 27;7:54. doi: 10.1186/1471-2407-7-54.
Epidemiological observations suggest that cancer arises from chronically inflamed tissues. Inflammatory bowel disease (IBD) is a typical example as patients with longstanding IBD are at an increased risk for developing colorectal cancer (CRC) and mutations of the NOD2/CARD15 gene increase the risk for Crohn's disease (CD). Recently, NOD2/CARD15 has been associated with a risk for CRC in some studies, which stemmed from ethnically diverse populations. Our aim was to identify common NOD2/CARD15 mutations in Hungarian patients with sporadic CRC.
A total of 194 sporadic CRC patients (m/f: 108/86, age at diagnosis of CRC: 63.2 +/- 9.1 years old) and 200 healthy subjects were included. DNA was screened for SNP8, SNP12 and SNP13 NOD2/CARD15 mutations by denaturing-HPLC and confirmed by direct sequencing.
NOD2/CARD15 mutations were found in 28 patients (14.4%) and in 23 controls (11.5%, p = NS). Allele frequencies for SNP8/R702W (1.8% vs. 1.5%) SNP12/G908R (1.8% vs. 1.8%) and SNP13/3020insC (3.6% vs. 2.5%) were also not statistically different between patients and controls. The clinicopathologic characteristics of CRC patients with or without NOD2/CARD15 mutations were not significantly different.
Our results suggest that common NOD2/CARD15 mutations alone do not contribute to CRC risk in the Hungarian population.
流行病学观察表明,癌症起源于慢性炎症组织。炎症性肠病(IBD)就是一个典型例子,因为长期患有IBD的患者患结直肠癌(CRC)的风险增加,而NOD2/CARD15基因突变会增加克罗恩病(CD)的风险。最近,在一些针对不同种族人群的研究中,NOD2/CARD15与CRC风险相关。我们的目的是确定匈牙利散发性CRC患者中常见的NOD2/CARD15突变。
共纳入194例散发性CRC患者(男/女:108/86,CRC诊断时年龄:63.2±9.1岁)和200名健康受试者。通过变性高效液相色谱法筛查DNA中的NOD2/CARD15基因SNP8、SNP12和SNP13突变,并通过直接测序进行确认。
在28例患者(14.4%)和23名对照者(11.5%,p=无统计学意义)中发现了NOD2/CARD15突变。患者和对照者之间SNP8/R702W(1.8%对1.5%)、SNP12/G908R(1.8%对1.8%)和SNP13/3020insC(3.6%对2.5%)的等位基因频率也无统计学差异。有无NOD2/CARD15突变的CRC患者的临床病理特征无显著差异。
我们的结果表明,仅常见的NOD2/CARD15突变不会增加匈牙利人群患CRC的风险。